Human papillomavirus vaccination and cervical cancer risk
L Rahangdale, C Mungo, S O'Connor, CJ Chibwesha… - Bmj, 2022 - bmj.com
Persistent human papillomavirus infection is the central cause of cervical cancer, the leading
cause of cancer death among women worldwide. Clear evidence from both randomized …
cause of cancer death among women worldwide. Clear evidence from both randomized …
Prophylactic human papillomavirus vaccination: from the origin to the current state
Immunization is the most successful method in preventing and controlling infectious
diseases, which has helped saving millions of lives worldwide. The discovery of the human …
diseases, which has helped saving millions of lives worldwide. The discovery of the human …
Vaccines for HPV-associated diseases
JM Skolnik, MP Morrow - Molecular Aspects of Medicine, 2023 - Elsevier
Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15 …
H Sharma, S Parekh, P Pujari, S Shewale… - The Lancet …, 2023 - thelancet.com
Background To meet global cervical cancer elimination efforts, a wider range of affordable
and accessible vaccines against human papillomavirus (HPV) are needed. We aimed to …
and accessible vaccines against human papillomavirus (HPV) are needed. We aimed to …
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
A Seyoum, B Seyoum, T Gure, A Alemu… - Scientific Reports, 2024 - nature.com
Abstract The World Health Organization [WHO] recommends a genotype-specific human
papillomavirus [HPV] vaccination as a primary prevention strategy to control the burden of …
papillomavirus [HPV] vaccination as a primary prevention strategy to control the burden of …
Human papillomavirus epidemiology and prevention: is there still a gender gap?
Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …
most common sexually transmitted infections (STIs) in both males and females, and the most …
Epidemiology, molecular pathogenesis, immuno-pathogenesis, immune escape mechanisms and vaccine evaluation for HPV-associated carcinogenesis
Human papillomavirus (HPV) is implicated in over 90% of cervical cancer cases, with factors
like regional variability, HPV genotype, the population studied, HPV vaccination status, and …
like regional variability, HPV genotype, the population studied, HPV vaccination status, and …
Copper in Gynecological Diseases
RA Conforti, MB Delsouc, E Zorychta… - International Journal of …, 2023 - mdpi.com
Copper (Cu) is an essential micronutrient for the correct development of eukaryotic
organisms. This metal plays a key role in many cellular and physiological activities …
organisms. This metal plays a key role in many cellular and physiological activities …
Trend of HPV molecular epidemiology in the post-vaccine era: A 10-year study
Cervical cancer, a major health concern among women worldwide, is closely linked to
human papillomavirus (HPV) infection. This study explores the evolving landscape of HPV …
human papillomavirus (HPV) infection. This study explores the evolving landscape of HPV …
Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis
R Lin, H Jin, X Fu - Expert review of vaccines, 2023 - Taylor & Francis
Objectives Despite their use, differences in human papillomavirus (HPV) vaccine efficacies
remain uncertain. This study assesses efficacy differences among bivalent, quadrivalent …
remain uncertain. This study assesses efficacy differences among bivalent, quadrivalent …